|
|
Volumn 11, Issue 1, 2011, Pages 4-6
|
|
Will sublingual immunotherapy become an approved treatment method in the united states?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
IMMUNOMODULATING AGENT;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
PLACEBO;
RAGWEED ANTIGEN;
AGE DISTRIBUTION;
ALLERGIC RHINITIS;
ASTHMA;
DRUG ADMINISTRATION ROUTE;
DRUG APPROVAL;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
DRUG INDICATION;
DRUG INFORMATION;
DRUG MEGADOSE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IMMUNOTHERAPY;
LOW DRUG DOSE;
OFF LABEL DRUG USE;
PRESCRIPTION;
REVIEW;
SUBLINGUAL IMMUNOTHERAPY;
UNITED STATES;
ADMINISTRATION, SUBLINGUAL;
DESENSITIZATION, IMMUNOLOGIC;
DRUG APPROVAL;
HUMANS;
PHYSICIAN'S PRACTICE PATTERNS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 79551554474
PISSN: 15297322
EISSN: None
Source Type: Journal
DOI: 10.1007/s11882-010-0157-4 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
